CRP and diabetic kidney disease: Although only observational in nature, these studies demonstrate that in patients with type 2 diabetes and diabetic kidney disease, circulating levels of C-reactive protein, fibrinogen, interleukin-6, and tumor necrosis factor are significantly increased.